Allegheny Financial Group LTD - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 62 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q1 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Allegheny Financial Group LTD ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2022$2,000
-66.7%
11,5950.0%0.00%
-66.7%
Q2 2022$6,000
-75.0%
11,5950.0%0.00%
-70.0%
Q1 2022$24,000
-50.0%
11,5950.0%0.01%
-47.4%
Q4 2021$48,000
-55.6%
11,5950.0%0.02%
-62.0%
Q3 2021$108,000–11,595–0.05%–
 Download
Other shareholders
BROOKLYN IMMUNOTHERAPEUTICS shareholders Q1 2022
NameSharesValueWeighting ↓
AJ WEALTH STRATEGIES, LLC 36,001$00.00%
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders